Adverse events: nausea · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ nausea compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse effects during treatment ‐ heaviness in lower abdomen · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ heaviness in lower abdomen compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse effects during treatment ‐ pain in abdomen · endometrial hyperplasia
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ pain in abdomen compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
2 findings from 1 review
Adverse events (spotting at 3 and 6 months) · women with uterine fibroids
1 finding from 1 review
Haemoglobin level ‐ Haemoglobin level at 12 months Scale from: 0 to 20. · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
1 finding from 1 review
Adverse events · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in fibroid related symptoms · women with uterine fibroids
1 finding from 1 review
Change in haemoglobin level from baseline · women with uterine fibroids
2 findings from 1 review
Fibroid size · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy rate · women seeking emergency contraception
1 finding from 1 review
Failed insertion · women seeking emergency contraception
It is very uncertain whether summary of findings table ‐ Levonorgestrel IUDs changes failed insertion compared with copper IUDs (very low certainty).
1 finding from 1 review
Expulsion by 6 months · women seeking emergency contraception
It is very uncertain whether summary of findings table ‐ Levonorgestrel IUDs changes rates of expulsion compared with copper IUDs (very low certainty).
1 finding from 1 review
Rates of removal · women seeking emergency contraception
It is very uncertain whether summary of findings table ‐ Levonorgestrel IUDs changes rates of removal compared with copper IUDs (very low certainty).
1 finding from 1 review
Number of bleeding days in first month · women seeking emergency contraception
1 finding from 1 review
Cramping · women seeking emergency contraception
1 finding from 1 review
Patient satisfaction · women seeking emergency contraception
It is very uncertain whether summary of findings table ‐ Levonorgestrel IUDs changes patient satisfaction compared with copper IUDs (very low certainty).
1 finding from 1 review
Regression rate at 6 months · women with atypical endometrial hyperplasia
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes regression rate at 6 months compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
1 finding from 1 review
Nausea · women with atypical endometrial hyperplasia
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes nausea over 6‐month compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
1 finding from 1 review